Published in Leukemia on March 11, 2010
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood (2011) 2.09
B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol (2013) 1.72
CD38 and chronic lymphocytic leukemia: a decade later. Blood (2011) 1.33
Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications. Hematol Oncol Clin North Am (2013) 1.22
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood (2011) 1.09
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab. Leukemia (2015) 1.01
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment. Biochim Biophys Acta (2015) 0.98
Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells. PLoS One (2011) 0.97
Cell Trafficking in Chronic Lymphocytic Leukemia. Open J Hematol (2012) 0.92
Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia. Front Biosci (Schol Ed) (2012) 0.91
"Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia''. Blood Cancer J (2013) 0.88
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. Leukemia (2014) 0.83
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia. Ann Hematol (2013) 0.83
ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation. PLoS One (2013) 0.79
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. Clin Cancer Res (2015) 0.78
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response. J Clin Invest (2015) 0.77
Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia. Oncoimmunology (2016) 0.76
Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight (2016) 0.75
Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia. PLoS One (2016) 0.75
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia. Clin Cancer Res (2016) 0.75
Targeting CD38 suppresses induction and function of T regulatory cells to mitigate immunosuppression in multiple myeloma. Clin Cancer Res (2017) 0.75
Cancer stem cell marker glycosylation: Nature, function and significance. Glycoconj J (2017) 0.75
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature (1998) 4.03
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 3.03
Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum (1997) 2.90
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol (1993) 2.56
200 injuries caused by playground equipment. Br Med J (1975) 2.55
Recognition of a peptide antigen by heat shock--reactive gamma delta T lymphocytes. Science (1990) 2.41
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21
Children and mini-magnets: an almost fatal attraction. Emerg Med J (2002) 2.05
Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr (2006) 2.03
Randomized clinical trial comparing primary closure with the Limberg flap in the treatment of primary sacrococcygeal pilonidal disease. Br J Surg (2005) 2.02
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol (2005) 1.95
Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum (1999) 1.94
Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry (2007) 1.86
Biosynthesis of mannophosphoinositides by Mycobacterium phlei. The family of dimannophosphoinositides. J Biol Chem (1967) 1.82
Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol (2001) 1.78
Recognition of heat shock proteins and gamma delta cell function. Immunol Today (1990) 1.76
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia (2012) 1.68
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics (1997) 1.68
Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol (1996) 1.67
Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer (2009) 1.66
Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) (1999) 1.66
The role of computerized tomography in the preoperative assessment of chronic suppurative otitis media. Clin Otolaryngol Allied Sci (2002) 1.64
CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J Thromb Haemost (2008) 1.62
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia (2012) 1.60
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
Repairing the degenerative mitral valve: ten- to fifteen-year follow-up. J Thorac Cardiovasc Surg (1996) 1.56
Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant (2010) 1.55
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.55
Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J Med Microbiol (1988) 1.54
Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer (2005) 1.54
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol (1985) 1.52
A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun (1993) 1.52
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood (2001) 1.52
Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum (1992) 1.51
The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood (1989) 1.51
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer (2009) 1.48
Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells. Leuk Res (2001) 1.46
Efficacy and safety of reuse of disposable laparoscopic instruments in laparoscopic cholecystectomy: a prospective randomized study. Surg Endosc (2004) 1.44
Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol (1994) 1.44
Reader practice in mammography screen reporting in Australia. J Med Imaging Radiat Oncol (2009) 1.42
Molecular pathophysiology of indolent lymphoma. Haematologica (2000) 1.42
Chlamydia trachomatis infection in children with wheezing simulating asthma. Lancet (1992) 1.42
Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res (2001) 1.41
p53 mutations are associated with histologic transformation of follicular lymphoma. Blood (1993) 1.40
'Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood (1991) 1.40
Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer (2001) 1.40
Bazex syndrome: acrokeratosis paraneoplastica in association with simultaneous multiple genitourinary tumors. Urology (2000) 1.39
Cyclosporin A in the treatment of B-chronic lymphocytic leukemia (B-CLL) Leukemia (1994) 1.39
New drainage technique in the ureteropelvic junction obstructions. Side-to-side ureterocalicostomy (or ureterocaliceal by-pass) preserving renal pelvis and ureteropelvic junction. Scand J Urol Nephrol (1998) 1.38
Commercialism in marketing. Br Dent J (2006) 1.38
Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology (2000) 1.38
Magnetic resonance imaging in the evaluation of cerebrospinal fluid fistulae. Clin Radiol (1996) 1.37
Transmission of prions. Proc Natl Acad Sci U S A (2002) 1.36
CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood (1996) 1.35
Anion conductance behavior of the glutamate uptake carrier in salamander retinal glial cells. J Neurosci (1996) 1.34
The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer (2004) 1.34
Vinculin, talin, and integrins are localized at specific adhesion sites of malignant B lymphocytes. Blood (1988) 1.33
Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med (1989) 1.32
Spatially segregated control of Ca2+ release in developing skeletal muscle of mice. J Physiol (1999) 1.31
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest (1985) 1.30
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS (2000) 1.30
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol (2008) 1.30
Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma. J Rheumatol (1995) 1.29
Human CD38, a cell-surface protein with multiple functions. FASEB J (1996) 1.29
Differential cognitive effects of colloid cysts in the third ventricle that spare or compromise the fornix. Brain (2000) 1.28
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol (1990) 1.28
Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood (1994) 1.28
Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol (1996) 1.27
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells. J Biol Chem (1997) 1.27
The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol (1996) 1.25
Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia (1998) 1.23
Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem (1996) 1.21
In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation. Proc Natl Acad Sci U S A (1998) 1.21
Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res (2000) 1.21
Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ (1990) 1.20
Capital costs of supporting young disabled people at home. Health Trends (1994) 1.20
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol (1986) 1.20
Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol (1996) 1.20
Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J (1999) 1.19
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS (2001) 1.19
Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenat Diagn (2010) 1.17
Birth complications combined with early maternal rejection at age 1 year predispose to violent crime at age 18 years. Arch Gen Psychiatry (1994) 1.17
Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood (2000) 1.16
6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood (1993) 1.16
Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood (1998) 1.16
Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Br J Haematol (1998) 1.16
Harrington instrumentation and arthrodesis for idiopathic scoliosis. A twenty-one-year follow-up. J Bone Joint Surg Am (1990) 1.15
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome. Ann Hematol (2004) 1.14
Adult intramedullary mature teratoma of the spinal cord: review of the literature illustrated with an unusual example. Acta Neurochir (Wien) (2006) 1.14